+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Roche Diagnostics Ltd. - logo

Founded in Basel, Switzerland in 1896, Roche produces innovative medicines and diagnostic tests for the early detection, prevention, diagnosis and treatment of diseases including oncology, rheumatology, virology, transplantation, diabetes and immunology. They are the world’s leading biotech company and have been at the forefront of cancer research and treatment for more than 50 years, in addition to being the leading provider of in vitro diagnostics.

Hairy Cell Leukemia - Global Strategic Business Report - Product Thumbnail Image

Hairy Cell Leukemia - Global Strategic Business Report

  • Report
  • September 2025
  • 273 Pages
  • Global
From
Aplastic Anemia - Global Strategic Business Report - Product Thumbnail Image

Aplastic Anemia - Global Strategic Business Report

  • Report
  • September 2025
  • 469 Pages
  • Global
From
Leukemia Screening - Global Strategic Business Report - Product Thumbnail Image

Leukemia Screening - Global Strategic Business Report

  • Report
  • September 2025
  • 487 Pages
  • Global
From
Lymphoma Treatment Market Report by Type, Test Type, Drug, and Region 2024-2032 - Product Thumbnail Image

Lymphoma Treatment Market Report by Type, Test Type, Drug, and Region 2024-2032

  • Report
  • August 2024
  • 146 Pages
  • Global
From
T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 182 Pages
  • Global
From
Mantle Cell Lymphoma Therapeutics Market Report 2025 - Product Thumbnail Image

Mantle Cell Lymphoma Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Diffuse Large B-cell Lymphoma Therapeutics Market Report 2025 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non Hodgkin Lymphoma (NHL) Market Report 2025 - Product Thumbnail Image

Non Hodgkin Lymphoma (NHL) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Follicular Lymphoma Treatment Market Report 2025 - Product Thumbnail Image

Follicular Lymphoma Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Home Healthcare Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service, Type, Indication, and Geography - Product Thumbnail Image

Home Healthcare Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service, Type, Indication, and Geography

  • Report
  • March 2025
  • 172 Pages
  • Global
From
Next-Generation Sequencing Market: Industry Outlook by Offering Application End User - Global Forecast to 2031 - Product Thumbnail Image

Next-Generation Sequencing Market: Industry Outlook by Offering Application End User - Global Forecast to 2031

  • Report
  • August 2024
  • 451 Pages
  • Global
From
Next Generation Antibody Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Next Generation Antibody Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 113 Pages
  • Global
From
2022 What's Next for Asia-Pacific Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers? - An 18-Country Analysis - Product Thumbnail Image

2022 What's Next for Asia-Pacific Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers? - An 18-Country Analysis

  • Report
  • August 2022
  • Asia Pacific
From
Hematology Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Hematology Diagnostics - Global Strategic Business Report

  • Report
  • September 2025
  • 174 Pages
  • Global
From
HER2-Negative Breast Cancer: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

HER2-Negative Breast Cancer: Global Drug Forecast and Market Analysis to 2028

  • Report
  • February 2020
  • 173 Pages
  • Global
From
Small Cell Lung Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis. - Product Thumbnail Image

OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis.

  • Report
  • September 2025
  • 428 Pages
  • Global
From
Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • March 2025
  • 183 Pages
  • Global
From
Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal Drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Drug Type, and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal Drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Drug Type, and Region with Growth Forecasts, 2025-2030

  • Report
  • February 2025
  • 150 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator